Victoza, Byetta, Januvia and others can lead to pancreatic cancer
Some studies and anecdotal reports have shown that pancreatitis may cause an individual to develop, or be at a higher risk to develop pancreatic cancer. Pancreatitis is defined as inflammation in the...
View ArticleGLP-1 therapy drugs lead to pancreatitis, pancreatitis dramatically increases...
Author S. Raimondi from the European Institute of Oncology in Milan, Italy, wrote an article titled “Pancreatic Cancer in Chronic Pancreatitis; Aetiology, Incidence, and Early Detection”. Chronic...
View Article2013 – Study links Byetta, Victoza, Januvia to pancreatitis, pancreatic cancer
Studies have shown that pancreatitis is associated with the use of exenatide (Byetta, Bydureon), liraglutide (Victoza), and sitagliptin (Januvia, Janumet, Janumet XR, Juvisync) and other glucagon like...
View Article2011 – Pancreatitis, Pancreatic, and Thyroid Cancer Associated with GLP-1...
In 2011, M. Elashoff, from the Larry L. Hillblom Islet Research Center at David Geffen School of Medicine and Department of Biomathematics at University of California, Los Angeles, published a study...
View Article2004 – Research Connects Pancreatitis and Pancreatic Cancer
Recent studies have shown that there is a positive correlation between pancreatic inflammation and an increased risk of pancreatic cancer. While acute pancreatitis that appears suddenly and may last...
View Article1995 – Pancreatitis found associated with pancreatic cancer
Author P. Bansal from the Division of Gastroenterology at the Department of Veterans Affairs Medical Center in Milwaukee, Wisconsin, conducted a study called “Pancreatitis is a Risk Factor For...
View Article
